Membrane distillation's niche: Memsift Innovations targets small-to-medium-scale zero liquid discharge

June 19, 2020 | Case Study

The treatment and disposal of liquid waste is a multibillion-dollar market industry globally. The market in China is over 50 billion m3 per year for waste streams generated from heavy industries and manufacturing – whereas in India, regulations to combat water scarcity by maximizing water reuse, and to limit pollution of surface waters, have created a market north of $1 billion per year for zero liquid discharge (ZLD) technologies (see the report). Tighter regulations on the discharge of toxic wastewater, particularly from heavy water-using industries, are also seeing an increase in brine volumes (the salt-laden concentrate left after waste treatment), which require disposal, giving a rise to a new flock of brine management technologies (see the insight). 

Memsift Innovations, led by Dr. J Antony Prince, a membrane specialist, is commercializing a membrane distillation (MD) technology using novel membrane chemistries to target the low-to-medium-volume ZLD segment (under 100 m3/day). The company has secured partnerships in China and Singapore and is first targeting waste treatment in order to reduce disposal costs for pharmaceutical and semiconductor manufacturers.

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978